Course Details
Course Title Early Hydrocortisone, Bronchopulmonary Dysplasia, and the PREMILOC Trial: A Practical Overview
Presented Date 11/08/2024
Expiration Date 11/25/2024

Presenter(s) Katie Chetta, M.D.
This Presenter does not have any relevant Financial Relationships to disclose.

This activity was supported by an education grant or any in-kind support.
Chiesi, USA

The Medical University of South Carolina designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description This video is part of the 2024 Neonatal Pharmacology Conference.
Objectives Examine the use of hydrocortisone in the very preterm population.
Recognize how hydrocortisone may impact adrenal insufficiency, bronchopulmonary dysplasia, and survival in extremely low birth weight infants.
Recall the evidence for PREMILOC (Early Low-Dose Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia in Extremely Preterm Infants) and its dosing for extremely low birth weight infants.
Step 1
Watch the course video.
Step 2
1. The below link will take you to the CME Tracker Publisher Portal. Please make sure that the settings on your computer, tablet or phone allows for "pop-ups"
2. Sign in (or create an account) to generate certificate
3. The activity code will self-populate, click “Submit”
4. A pop-up box will appear that says “This activity has a required test” click “ok”
5. Complete the quiz. You will need to score 100%. You can retake the quiz as many times as necessary.
6. After completing the quiz, click “Continue” and “ok” when the score of 100% appears
7. Complete the evaluation and then “Submit”
8. Print or save your credit letter

CME Tracker - Claim Credit

Help

If you experience technical or accessibility issues, have questions about CME webcasting, or need assistance with webcast CME credit, please email us.